Last week, Waymo, the self-driving vehicle developer owned by Alphabet, expanded a first-of-its-kind service offering rides to paying passengers around Phoenix--with no one behind the wheel. Videos shared by Waymo and others show its minivans navigating wide, sunny streets with ease. Now rival Cruise, a General Motors subsidiary, has taken a step towards running its own self-driving taxi service--on the hilly, winding, pedestrian-swarmed streets of San Francisco. On Thursday, Cruise said the California Department of Motor Vehicles had granted it a permit to test up to five of its modified Chevy Bolts without anyone behind the wheel. In a blog post, Cruise CEO Dan Ammann said truly driverless cars would operate in the city before the end of the year.

Over a billion people every day use Google Search, the company said. Despite having worked on the software for more than 20 years, every day there are 15 percent of queries that Google has never seen before. To keep up with the constantly changing queries, sources of information and ways to present results, Google needs to tap the power of AI. Today, the company announced a set of updates that can make Search easier to use, and the most notable of these is a new "Hum to Search" feature that's avalable today. It's like Shazam or Soundhound for song identification, except you don't need to have the music playing.

ARMONK, NY and SANTA CLARA, CA, October 15, 2020 – IBM (NYSE: IBM) and ServiceNow (NYSE: NOW) today announced an expansion to their strategic partnership designed to help companies reduce operational risk and lower costs by applying AI to automate IT operations. Available later this year, a new joint solution will combine IBM's AI‑powered hybrid cloud software and professional services to ServiceNow's intelligent workflow capabilities and market‑leading IT service and operations management products. The solution is engineered to help clients realize deeper, AI‑driven insights from their data, create a baseline of a typical IT environment, and take succinct recommended actions on outlying behavior to help prevent and fix IT issues at scale. Together, IBM and ServiceNow can help companies free up valuable time and IT resources from maintenance activities, to focus on driving the transformation projects necessary to support the digital demands of their businesses. "AI is one of the biggest forces driving change in the IT industry to the extent that every company is swiftly becoming an AI company," said Arvind Krishna, Chief Executive Officer, IBM.

Boston, MA – Scientists working at the intersection of Artificial Intelligence (AI) and cancer care need to be more transparent about their methods and publish research that is reproducible, according to a new commentary co-authored by John Quackenbush, Henry Pickering Walcott Professor of Computational Biology and Bioinformatics and chair of the Department of Biostatistics at Harvard T.H. Chan School of Public Health. "The foundation of the scientific method is that research results must be testable by others. Testability is even more important in clinical applications because we need a high level of confidence in our methods before they are used with patients," Quackenbush said. "In applications of Artificial Intelligence, this requires that the models, software code, and data are available for independent validation. Transparency will accelerate research, advance patient care, and will build confidence among scientists and clinicians."

PHILADELPHIA – As the search for successful Alzheimer's disease drugs remains elusive, experts believe that identifying biomarkers -- early biological signs of the disease -- could be key to solving the treatment conundrum. However, the rapid collection of data from tens of thousands of Alzheimer's patients far exceeds the scientific community's ability to make sense of it. Now, with a $17.8 million grant from the National Institute on Aging at the National Institutes of Health, researchers in the Perelman School of Medicine at the University of Pennsylvania will collaborate with 11 research centers to determine more precise diagnostic biomarkers and drug targets for the disease, which affects nearly 50 million people worldwide. For the project, the teams will apply advanced artificial intelligence (AI) methods to integrate and find patterns in genetic, imaging, and clinical data from over 60,000 Alzheimer's patients -- representing one of the largest and most ambitious research undertakings of its kind. Penn Medicine's Christos Davatzikos, PhD, a professor of Radiology and director of the Center for Biomedical Image Computing and Analytics, and Li Shen, PhD, a professor of Informatics, will serve as two of five co-principal investigators on the five-year project.

Corp. (PINKSHEETS: GCKO) -- announced today that one of their care giver participants has "looked in" on her mother while shopping. Her testimonial characterizes some of the benefits she is realizing from the CareBot and its remote monitoring and telepresence capabilities. GeckoSystems is a dynamic leader in the emerging Mobile Service Robot (MSR) industry revolutionizing their development and usage with their "Mobile Robot Solutions for Safety, Security, and Service ". "In the past I have not been able to'look in' on my elderly mother at home alone while I was out shopping. There was always a concern if she was okay during my absence, especially if she had some new health issue. Today, for the first time, I was able to watch her while grocery shopping at Ingles with the help of her CareBot. "I took my Dell netbook with me.

A report on the findings was published in the October 2020 issue of the journal Computers in Biology and Medicine. APL scientists developed and tested several deep learning computer models to accurately pick out EM from other dermatological conditions and normal skin. The DL models were "trained" to discern the appearance of EM using images of non-EM rashes and normal skin available in the public domain, and clinical photos of patients with EM provided by the Johns Hopkins University Lyme Disease Research Center and the Lyme Disease Biobank, part of the Johns Hopkins University School of Medicine's Division of Rheumatology. There are more than 300,000 new cases of Lyme disease annually in the United States and treatment is most effective if it is caught early. Misdiagnosis, especially in the disease's initial stages, is common because of several challenges.

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading artificial intelligence-based cybersecurity market vendors that include Amazon.com Inc., AO Kaspersky Lab, Broadcom Inc., Check Point Software Technologies Ltd., Cisco Systems Inc., Dell Technologies Inc., Fortinet Inc., Hewlett Packard Enterprise Co., Intel Corp., and International Business Machines Corp. Also, the artificial intelligence-based cybersecurity market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

GE Healthcare (NYSE:GE) announced that it received FDA 510(k) clearance for its Ultra Edition package on Vivid cardivascular ultrasound systems. The Ultra Edition package on Vivid cardiovascular ultrasound systems includes new features that are based on artificial intelligence (AI) designed to enable clinicians to acquire faster, more repeatable exams on a consistent basis, according to a news release. Vivid Ultra Edition reduces exam time through up to 80% fewer clicks, 99% accuracy and less inter-operator variability, the company said. The AI features within the Vivid Ultra Edition includes automatic detection of the appropriate measurement of spectral Doppler images and relevant points in the image for deriving measurements of the left ventricle, along with view recognition for which standard 2D scan plane is acquired. Other features include HD color displays, FlexiLight for improving visualizations and a 4D TTE pediatric probe for 2D and 4D imaging in pediatric patients ranging from neonates to teenagers.

Ai VentureTech is pleased to announce it has joined the IBM PartnerWorld program, which will be an integral part in our development of Deep Sky Wireless, Realm Robotics, and Next Realm AI. What Does This Mean for the Company? As a Registered Business Partner, AI VentureTech will now have access to IBM's wide assortment of developer solutions in the areas of Artificial Intelligence (A.I.), Cloud, Security, IT Infrastructure, Watson, and Watson Health. From infrastructure, to training, IBM suite of solutions can provide our company with all the technology needed to build out world-class A.I. and cloud-based solutions for commercial markets. As an AI consulting firm, we will now be able to resell IBM suite of solutions to clients to offer real world technology products and solutions on which to generate revenues from.